Advertisement
Canada markets open in 5 hours 37 minutes
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7311
    -0.0009 (-0.12%)
     
  • CRUDE OIL

    83.33
    -0.03 (-0.04%)
     
  • Bitcoin CAD

    91,135.30
    +542.73 (+0.60%)
     
  • CMC Crypto 200

    1,418.08
    -6.02 (-0.42%)
     
  • GOLD FUTURES

    2,334.60
    -7.50 (-0.32%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • NASDAQ futures

    17,710.75
    +104.00 (+0.59%)
     
  • VOLATILITY

    15.73
    +0.04 (+0.25%)
     
  • FTSE

    8,076.04
    +31.23 (+0.39%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6837
    +0.0001 (+0.01%)
     

Stocks in play: Abattis Bioceuticals Corp.

Announced the addition of three new vaporizers to its product line. Since the Company’s acquisition of Green Tree Therapeutics earlier this year, Abattis has been working to expand its retail presence and product line and is now ready to release its first three vaporizers, the VB-1, VB-2 and the KB-1. Abattis Bioceuticals Corp. shares ATT:CNX are trading up 1 cent at $0.21.